Chirnside E D, de Vries A A, Mumford J A, Rottier P J
Department of Infectious Diseases, Animal Health Trust, Kennett, Newmarket, UK.
J Gen Virol. 1995 Aug;76 ( Pt 8):1989-98. doi: 10.1099/0022-1317-76-8-1989.
Complementary DNAs encoding ORFs 2 to 7 equine arteritis virus (EAV) have been cloned into the expression vector pGEX to produce glutathione-S-transferase fusion proteins. Recombinant proteins were affinity purified and screened in ELISA with equine sera to identify immunoreactive polypeptides. The large envelope glycoprotein (GL) was identified as the most reactive to EAV-positive equine sera and an immuno-dominant epitope was mapped between amino acids 55 and 98 by subcloning and expression. A fusion protein covering this region and a GL-specific synthetic peptide (residues 75 through 97) induced EAV-neutralizing antibody in vaccinated horses. The defined antigenic region of GL is likely to be exposed on the surface of the native EAV virion and consequently may be useful in the development of diagnostic tests and vaccines.
编码马动脉炎病毒(EAV)开放阅读框2至7的互补DNA已被克隆到表达载体pGEX中,以产生谷胱甘肽-S-转移酶融合蛋白。重组蛋白经亲和纯化后,用马血清进行ELISA筛选,以鉴定免疫反应性多肽。大囊膜糖蛋白(GL)被确定为对EAV阳性马血清反应最强的蛋白,通过亚克隆和表达,在氨基酸55至98之间定位了一个免疫显性表位。覆盖该区域的融合蛋白和GL特异性合成肽(第75至97位氨基酸残基)在接种疫苗的马匹中诱导产生了EAV中和抗体。GL确定的抗原区域可能暴露在天然EAV病毒粒子的表面,因此可能有助于诊断测试和疫苗的开发。